22 results
6-K
BYSI
BeyondSpring Inc
18 Apr 23
Current report (foreign)
4:37pm
.
Decheng Capital is an investment firm that provides capital and strategic support to early-stage life science companies and growth stage healthcare
6-K
EX-99.1
BYSI
BeyondSpring Inc
30 Dec 21
Current report (foreign)
12:30pm
of Directors in November 2021. Mr. Santos has more than 30 years of experience in healthcare industries. He is SVP of Pharma Strategy & Contracting
6-K
EX-99.1
BYSI
BeyondSpring Inc
10 Nov 21
BeyondSpring Appoints Commercial Leader Mark Santos to its Board of Directors
4:05pm
of executive experience across the healthcare and pharmaceutical industries, currently serving as the Senior Vice President of Pharma Strategy & Contracting
6-K
EX-99.1
wukqv lzlmjp0ti2vpot
26 Aug 21
BeyondSpring Announces Exclusive Commercialization and Co-development Agreement with Jiangsu Hengrui Pharmaceuticals for Plinabulin in Greater China
7:15am
6-K
EX-99.1
wk2ei40
11 Jun 20
BeyondSpring Reports First-Quarter 2020 Financial Results and Operational Update
4:15pm
424B5
pj3qaby2lwy
18 Jul 19
Prospectus supplement for primary offering
4:19pm
424B5
ck0gglcaoal8bfhe50q
16 Jul 19
Prospectus supplement for primary offering
5:18pm
6-K
qo5af3ktyrk4
10 Jul 19
Current report (foreign)
11:32am
6-K
EX-99.1
2vjwij46but1
10 Jul 19
BeyondSpring Provides Operational Update and First Quarter 2019 Financial Results
11:22am
6-K
EX-1.1
4yofzhwka24 4lft5n8
22 May 19
Current report (foreign)
4:01pm
6-K
EX-99.1
avwvebc5
21 Jun 18
BeyondSpring Reports Operational Updates and First Quarter 2018 Financial Results
6:07am
CORRESP
cc7 q89froy
16 May 18
Correspondence with SEC
12:00am